Skip to content
10-K

Annual Report

FibroBiologics, Inc. FBLG

0001193125-26-066965

← back to feed
Filed
Feb 24, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2025 · Dec 31, 2025 44.66M sh
Shares Diluted FY 2025 · Dec 31, 2024 32.88M sh
Capex FY 2025 · Dec 31, 2025 $262K
Capex FY 2025 · Dec 31, 2024 $184K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$16.39M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$11.9M
Cash And Equivalents FY 2025 · Dec 31, 2025 $4.89M
Cash And Equivalents FY 2025 · Dec 31, 2024 $13.99M
Stockholders Equity FY 2025 · Dec 31, 2025 $6.16M
Stockholders Equity FY 2025 · Dec 31, 2024 $2.74M
Stockholders Equity FY 2025 · Dec 31, 2023 $1.25M
Current Liabilities FY 2025 · Dec 31, 2025 $1.76M
Current Liabilities FY 2025 · Dec 31, 2024 $12.73M
Total Liabilities FY 2025 · Dec 31, 2025 $3.46M
Total Liabilities FY 2025 · Dec 31, 2024 $13.71M
Current Assets FY 2025 · Dec 31, 2025 $6.35M
Current Assets FY 2025 · Dec 31, 2024 $14.23M
Total Assets FY 2025 · Dec 31, 2025 $9.62M
Total Assets FY 2025 · Dec 31, 2024 $16.45M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.42
Eps Diluted FY 2025 · Dec 31, 2024 −$0.34
Eps Basic FY 2025 · Dec 31, 2025 −$0.42
Eps Basic FY 2025 · Dec 31, 2024 −$0.34
Sga Expense FY 2025 · Dec 31, 2025 $9.24M
Sga Expense FY 2025 · Dec 31, 2024 $9.23M
Rd Expense FY 2025 · Dec 31, 2025 $7.41M
Rd Expense FY 2025 · Dec 31, 2024 $4.5M
Net Income FY 2025 · Dec 31, 2025 −$18.65M
Net Income FY 2025 · Dec 31, 2024 −$11.16M
Operating Income FY 2025 · Dec 31, 2025 −$16.65M
Operating Income FY 2025 · Dec 31, 2024 −$13.74M